Dec. 19 at 9:41 AM
$OM Outset Medical (OM) is a beaten-down healthcare stock trading like the market has given up on it, with shares down ~75%+ and valued at just 0.4–0.6x sales and under 1x book, as if its dialysis machines are headed for a yard sale. The company isn’t profitable yet (no P/E for a reason), but it has real revenue, a recurring consumables model, and a balance sheet that’s still standing. In essence, OM is priced for ongoing disappointment — so if execution improves even a little, the valuation alone could drive a sharp rebound, making this a classic “laugh now, maybe profit later” turnaround bet.
$DNUT $AMC $GME $TSLA
